373 related articles for article (PubMed ID: 26013701)
1. Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats.
Helmy MW; El-Gowelli HM; Ali RM; El-Mas MM
Br J Pharmacol; 2015 Sep; 172(17):4291-302. PubMed ID: 26013701
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling.
El-Mas MM; Helmy MW; Ali RM; El-Gowelli HM
Toxicol Appl Pharmacol; 2015 Apr; 284(1):1-7. PubMed ID: 25656942
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-β1/IL-2/COX-2/endothelin ET(B) receptor cascade.
El-Gowelli HM; Helmy MW; Ali RM; El-Mas MM
Toxicol Appl Pharmacol; 2014 Mar; 275(2):88-95. PubMed ID: 24462674
[TBL] [Abstract][Full Text] [Related]
4. Enhanced lipoxygenase/LTD4 signaling accounts for the exaggerated hypertensive and nephrotoxic effects of cyclosporine plus indomethacin in rats.
Helmy MW; Helmy MM; El-Mas MM
Biomed Pharmacother; 2018 Jun; 102():309-316. PubMed ID: 29571015
[TBL] [Abstract][Full Text] [Related]
5. Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions.
Nasser SA; Elmallah AI; Sabra R; Khedr MM; El-Din MM; El-Mas MM
Eur J Pharmacol; 2014 Mar; 727():52-9. PubMed ID: 24486390
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity.
Hammoud SH; Alkhansa S; Mahjoub N; Omar AG; El-Mas MM; Eid AA
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F572-F582. PubMed ID: 29767558
[TBL] [Abstract][Full Text] [Related]
7. The effect of low-dose Continuous Erythropoietin receptor activator in an experimental model of acute Cyclosporine A induced renal injury.
Meerwein C; Korom S; Arni S; Inci I; Weder W; Jungraithmayr W
Eur J Pharmacol; 2011 Dec; 671(1-3):113-9. PubMed ID: 21968143
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of cystathionine-γ-lyase/hydrogen sulfide pathway underlies the celecoxib counteraction of cyclosporine-induced hypertension and renal insult in rats.
Helmy MM; Helmy MW; El-Mas MM
Prostaglandins Other Lipid Mediat; 2019 Apr; 141():1-10. PubMed ID: 30658157
[TBL] [Abstract][Full Text] [Related]
9. Renoprotection with pituitary adenylate cyclase-activating polypeptide in cyclosporine A-induced nephrotoxicity.
Khan AM; Li M; Brant E; Maderdrut JL; Majid DS; Simon EE; Batuman V
J Investig Med; 2011 Jun; 59(5):793-802. PubMed ID: 21383633
[TBL] [Abstract][Full Text] [Related]
10. Modulation by NADPH oxidase of the chronic cardiovascular and autonomic interaction between cyclosporine and NSAIDs in female rats.
El-Yazbi AF; Ibrahim KS; El-Gowelli HM; El-Deeb NM; El-Mas MM
Eur J Pharmacol; 2017 Jul; 806():96-104. PubMed ID: 28416371
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of tea polyphenols on transforming growth factor-beta1 expression in rat with cyclosporine A-induced chronic nephrotoxicity.
Shi SH; Zheng SS; Jia CK; Zhu YF; Xie HY
Acta Pharmacol Sin; 2004 Jan; 25(1):98-103. PubMed ID: 14704129
[TBL] [Abstract][Full Text] [Related]
12. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
13. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Shihab FS; Yi H; Bennett WM; Andoh TF
Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
Sun QL; Li M; Rui HL; Chen YP
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):301-10. PubMed ID: 25500744
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
Yang CW; Ahn HJ; Kim WY; Li C; Kim HW; Choi BS; Cha JH; Kim YS; Kim J; Bang BK
Kidney Int; 2002 Jul; 62(1):20-30. PubMed ID: 12081560
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 receptor antagonists protect the kidney against the nephrotoxicity induced by cyclosporine-A in normotensive and hypertensive rats.
Caires A; Fernandes GS; Leme AM; Castino B; Pessoa EA; Fernandes SM; Fonseca CD; Vattimo MF; Schor N; Borges FT
Braz J Med Biol Res; 2017 Dec; 51(2):e6373. PubMed ID: 29267497
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
[TBL] [Abstract][Full Text] [Related]
18. Blockade of angiotensin II with losartan attenuates transforming growth factor-beta1 inducible gene-h3 (betaig-h3) expression in a model of chronic cyclosporine nephrotoxicity.
Sun BK; Li C; Lim SW; Choi BS; Lee SH; Kim IS; Kim YS; Bang BK; Yang CW
Nephron Exp Nephrol; 2005; 99(1):e9-16. PubMed ID: 15637465
[TBL] [Abstract][Full Text] [Related]
19. Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats.
Kon V; Hunley TE; Fogo A
Transplantation; 1995 Jul; 60(1):89-95. PubMed ID: 7624949
[TBL] [Abstract][Full Text] [Related]
20. Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity.
Shihab FS; Bennett WM; Yi H; Andoh TF
Am J Transplant; 2002 Feb; 2(2):111-9. PubMed ID: 12099512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
